LOSCHELDER advises FRESENIUS on investment in Avelios Medical
LOSCHELDER advised Fresenius SE & Co. KGaA on an investment in Avelios Medical GmbH.
Fresenius, together with SAP, is investing in Avelios Medical, a company developing a next-generation, cloud-native hospital information system. This marks a further step forward in the strategic partnership between Fresenius and SAP announced in January this year. The objective of the collaboration is to build an open, interoperable, and AI-enabled digital healthcare ecosystem for Germany and Europe. To this end, Fresenius and its technology partner SAP are combining clinical expertise, technological capabilities, and innovative product development to create a new digital infrastructure for hospitals across Europe.
The strategic investment in Avelios Medical is a key building block of this ecosystem. Avelios Medical is developing a modular hospital information system that enables end-to-end digitalization of clinical and administrative processes and is based on open standards. The solution allows for sovereign data usage, high interoperability, and the responsible integration of AI applications. This creates a scalable platform that relieves care teams, harmonizes processes, and accelerates the adoption of innovation in clinical practice.
“We are bringing together what Germany and Europe need in healthcare: medical excellence, technological strength, and the sovereign use of digitalization and AI,” said Christian Pawlu, Chief Operating Officer of Fresenius Helios. “With our investment in Avelios Medical, we are taking another step in building a digital healthcare ecosystem - nteroperable, reliable, and AI-ready.”
“We founded Avelios with the conviction that the future of healthcare lies in a data-driven, AI-native, and open health platform,” commented Christian Albrecht, Co-Founder and CEO of Avelios. “With SAP and Fresenius, we are bringing leading technological and clinical expertise to the table - and taking a decisive step toward an open ecosystem for the healthcare industry. This partnership validates our approach, our product, and our team.”
The close collaboration between Fresenius, SAP, and Avelios Medical supports the consistent, clinically driven development of the Avelios solution and accelerates its reliable scaling across the broader healthcare.
Fresenius was advised by: Dr. Simon Kohm (IT Law and Regulation), Dr. Sebastian Kalb, MBA (Corporate Law/M&A) (both leading), Dr. Kristina Schreiber (Data Protection Law and Regulation), Dr. Patrick Pommerening (IP), Arne Gehrke, LL.M. (Employment Law), Dr. Svenja Fröhlich (Corporate Law/M&A) as well as the Associates Simone Davepon,LL.M., Verena Hellmund (all Corporate Law/M&A), Dennis Pethke LL.M. (IT Law and Regulation), Rebecca Moßner (Data Protection Law) and Dr. Sebastian Krülls (Employment Law).
